Market: NASD |
Currency: USD
Address: 1035 Cambridge Street
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
📈 Eterna Therapeutics Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
200-500%
-
Upcoming Earnings Date:
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.066667 |
- |
2025-06-12 |
- |
Stock split |
|
Total Amount for 2025: $0.066667 |
| 2022 |
- |
$0.050000 |
- |
2022-10-17 |
- |
Stock split |
|
Total Amount for 2022: $0.050000 |
| 2021 |
- |
$0.500000 |
- |
2021-03-26 |
- |
Stock split |
|
Total Amount for 2021: $0.500000 |
| 2016 |
- |
$0.020000 |
- |
2016-06-17 |
- |
Stock split |
|
Total Amount for 2016: $0.020000 |
📅 Earnings & EPS History for Eterna Therapeutics Inc.
| Date | Reported EPS |
|---|
| 2022-11-14 | -37.35 |
| 2022-08-11 | -18 |
| 2022-07-01 | -51 |
| 2022-04-15 | - |
| 2021-11-12 | -510 |
📰 Related News & Research
No related articles found for "eterna therapeutics".
